Search

Objectives: In official judo competitions, athletes usually engage in 5-7 matches in the same day, performing numerous high-intensity efforts interspersed by short recovery intervals. Thus, glycolytic demand in judo is high and acidosis may limit performance. Carnosine is a relevant intracellular acid buffer whose content is increased with beta-alanine supplementation. Thus, we hypothesized that beta-alanine supplementation could attenuate acidosis and improve judo performance., Design: Twenty-three highly-trained judo athletes were randomly assigned to receive either beta-alanine (6.4gday -1 ) or placebo (dextrose, same dosage) for 4 weeks., Methods: Performance was assessed before (PRE) and after (POST) supplementation through a 5-min simulated fight (randori) followed by 3 bouts of the Special Judo Fitness Test (SJFT). Blood samples were collected for blood pH, bicarbonate (HCO 3 - ) and lactate determination., Results: Beta-alanine supplementation improved the number of throws per set and the total number of throws (both p<0.05). Placebo did not change these variables (both p>0.05). Blood pH and HCO 3 - reduced after exercise (all p<0.001), with no between-group differences (all p>0.05). However, the lactate response to exercise increased in the beta-alanine group as compared to placebo (p<0.05)., Conclusions: In conclusion, 4 weeks of beta-alanine supplementation effectively enhance judo-related performance in highly-trained athletes., (Copyright © 2016 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.)

Purpose: For the first time, we investigated the effects of altering cellular metabolic capacitance, via a 5-d creatine (Cr) loading protocol (20 g·d⁻¹), on oxygen uptake (VO2), accumulated oxygen deficit, muscle recruitment, and performance during a 1-km cycling time trial., Methods: In a double-blind, randomized, placebo-controlled design, 19 amateur cyclists were allocated to a Cr (n = 10, VO2peak = 56.0 ± 7.8 mL·kg⁻¹·min⁻¹) or placebo (n = 9, VO2peak = 56.0 ± 8.4 mL·kg⁻¹·min⁻¹) group, and performed a 1-km cycling time trial before and after the supplementation period., Results: Body mass was significantly increased in the Cr group (P < 0.05), but not in the placebo group. Participants adopted an "all-out" pacing strategy in both groups. However, Cr loading reduced VO2 immediately after the beginning (12th to 23th seconds), and this was accompanied by a reduced aerobic and increased anaerobic contribution. The VO2 mean response time was slower (pre: 17.2 ± 5.6 s vs post: 19.9 ± 4.6 s), the total O2 uptake was reduced (pre: 4.64 ± 0.59 L vs post: 4.47 ± 0.53 L), and the oxygen deficit was increased (pre: 0.82 ± 0.27 L vs post: 0.98 ± 0.25 L) after Cr loading. No differences were observed in the placebo group for these variables. Plasma lactate and integrated electromyography were not altered in either group, nor was the time to complete the trial (Cr group: pre: 89.1 ± 6.7 s vs post 89.1 ± 6.2 s and placebo group: pre 85.9 ± 4.9 s vs post 87.0 ± 5.4 s)., Conclusion: Cr loading slows the V˙O2 response and increases the anaerobic contribution during a 1-km cycling time trial.